- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04850131
Desarda Repair Compared to Lichtenstein Repair for the Treatment of Inguinal Hernias
April 14, 2021 updated by: Muhammad Usman Ghani, Benazir Bhutto Hospital, Rawalpindi
Mesh Free Desarda Repair Compared With Lichtenstein Repair for the Treatment of Primary Inguinal Hernias
The Lichtenstein technique for hernia repair is safe and simple, but the underlying mesh prosthesis has its setbacks, as it acts as a mechanical barrier5.
The mesh does not provide mobile and the physiologically dynamic posterior wall.
The most dangerous complication associated with the mesh prosthesis is its migration from the abdominal cavity's primary implantation site.
The relatively knew technique developed by Dr. Desarda does not utilize the synthetic mesh rather it uses a strip of external oblique aponeurosis to strengthen the posterior wall.
Our study has compared the two methods regarding various aspects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
82
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46000
- Benazir Bhutto Hospital Rawalpindi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients of age between 20 to 70years
- A primary inguinal hernia
- Consented to participate in the research.
Exclusion Criteria:
- Age below 20,
- Recurrent and pantaloons hernia
- Patients who did not give the informed consent
- Patients who lose the follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Desarda
Forty-one patients who were randomly assigned to the Desarda group underwent the Desarda repair for their problem.
Patients were followed for various data point values during operation, immediately after the operation, and for a period of one year post-operatively.
|
Desarda is a new tissue-based technique developed from applying the externally oblique muscle aponeurosis in the form of an undetached strip making the posterior wall in the inguinal canal stiffer.
This paper focuses on analyzing comparisons between mesh-free Desarda repair and the Lichtenstein technique for the treatment of hernia inguinalis
Other Names:
|
ACTIVE_COMPARATOR: Lichtenstein
Forty-one patients randomly assigned to the Lichtenstein group underwent the standard mesh repair and were followed for the same data point values and variables for the same specified period of time.
|
Desarda is a new tissue-based technique developed from applying the externally oblique muscle aponeurosis in the form of an undetached strip making the posterior wall in the inguinal canal stiffer.
This paper focuses on analyzing comparisons between mesh-free Desarda repair and the Lichtenstein technique for the treatment of hernia inguinalis
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative pain
Time Frame: 24 hours after the surgery
|
Measured on Visual analogue scale (VAS) where 0 meaning no pain and 10 means worst pain
|
24 hours after the surgery
|
Postoperative pain
Time Frame: 3 months after the primary surgery
|
Measured on Visual analogue scale (VAS) where 0 meaning no pain and 10 means worst pain
|
3 months after the primary surgery
|
Recurrence
Time Frame: Within 01 year of the primary surgery
|
Described as reappearance of the inguinal hernia on the operated side
|
Within 01 year of the primary surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wound complication
Time Frame: Complications occuring within 30 days after the surgery
|
Described as number of patients developing the wound complications like seroma , hematoma formation and surgical site infection.
|
Complications occuring within 30 days after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: MUHAMMAD USMAN GHANI, FCPS, Benazir Bhutto Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2019
Primary Completion (ACTUAL)
March 30, 2020
Study Completion (ACTUAL)
March 30, 2021
Study Registration Dates
First Submitted
April 10, 2021
First Submitted That Met QC Criteria
April 14, 2021
First Posted (ACTUAL)
April 20, 2021
Study Record Updates
Last Update Posted (ACTUAL)
April 20, 2021
Last Update Submitted That Met QC Criteria
April 14, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 274/IREF\RMU\2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recurrence
-
Portuguese Oncology Institute, CoimbraCompletedColorectal Cancer | Recurrence, Local NeoplasmPortugal
-
Chinese PLA General HospitalRecruitingHCC | Recurrence TumorChina
-
Paracelsus Medical UniversityHeinrich-Heine University, Duesseldorf; Poznan University of Medical Sciences; University Hospital of Ferrara and other collaboratorsCompletedToxicity | Local Neoplasm RecurrenceAustria
-
General Hospital GroeningeUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; University Hospital, Ghent and other collaboratorsNot yet recruiting
-
Dallas VA Medical CenterTerminatedSolid Tumors | Cancer RecurrenceUnited States
-
The University of Hong KongHealth and Medical Research FundNot yet recruitingCancer | Fear of Cancer Recurrence
-
German Centre for Assessment and Evaluation of...Not yet recruitingComplication | Continence | Potency | Biochemical RecurrenceGermany
-
The University of Hong KongNot yet recruitingCancer | Fear of Cancer Recurrence
-
RottapharmTerminatedHCV Recurrence After Liver Transplantation
-
The University of Hong KongHealth and Medical Research FundNot yet recruitingCancer | Fear of Cancer Recurrence | Psychooncology
Clinical Trials on Desarda repair
-
Makerere UniversityMulago Hospital, UgandaUnknown
-
Nicolaus Copernicus UniversityTerminatedHernia, InguinalPoland
-
Adrien SchwitzguebelRecruitingAnterior Cruciate Ligament Rupture | SurgerySwitzerland
-
University of AlexandriaCompletedPostoperative Complications | Bilateral Inguinal Hernia
-
University of Sao PauloUniversity of Sao Paulo General Hospital; Federal University of São Paulo; Irmandade... and other collaboratorsUnknown
-
IRCCS San RaffaeleCompletedThoracoabdominal Aortic AneurysmsItaly
-
Oulu University HospitalHelsinki University Central Hospital; Kuopio University Hospital; Seinajoki Central... and other collaboratorsUnknownIncisional Hernia
-
Uppsala University HospitalTyco Healthcare Group; Stig and Ragna Gorthon FoundationCompleted